Glial cells and chronic pain: From the laboratory to clinical hope;Cellules gliales et douleur chronique: Du laboratoire à l'espoir clinique

Revue Medicale Suisse

Volumn 9, Issue 392, 2013, Pages 1342-1345

  Clarke, C B ^a,b   Suter, M R ^a,b   Gosselin, R D ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DILMAPIMOD; IBUDILAST; LOSMAPIMOD; MINOCYCLINE; PENTOXIFYLLINE;

ASTROCYTE; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; GLIA CELL; HUMAN; MICROGLIA; REVIEW;

ANALGESICS, NON-NARCOTIC; ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; MICROGLIA; NEUROGLIA; PAIN, INTRACTABLE; TREATMENT OUTCOME;

EID: 84880273066     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. * Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
2. Narita M, Yoshida T, Nakajima M, et al. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem 2006;97:1337-48. (Pubitemid 43725573)
3. Tsuda M, Shigemoto-Mogami Y, Koizumi S, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003;424:778-83. (Pubitemid 37021707)
4. ** Gosselin RD, Suter MR, Ji RR, Decosterd I. Glial cells and chronic pain. Neuroscientist 2010;16:519-31.
5. ** Benarroch EE. Central neuron-glia interactions and neuropathic pain: Overview of recent concepts and clinical implications. Neurology 2010;75:273-8.
6. Shi Y, Gelman BB, Lisinicchia JG, Tang SJ. Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients. J Neurosci 2012;32:10833-40.
7. Banati RB, Cagnin A, Brooks DJ, et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 2001;12:3439-42. (Pubitemid 33065473)
8. Del Valle L, Schwartzman RJ, Alexander G. Spinal cord histopathological alterations in a patient with long-standing complex regional pain syndrome. Brain Behav Immun 2009;23:85-91.
9. Alexander GM, Perreault MJ, Reichenberger ER, Schwartzman RJ. Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome. Brain Behav Immun 2007;21:668-76. (Pubitemid 46829771)
10. Clark AK, Gentry C, Bradbury EJ, McMahon SB. Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur J Pain 2007;11:223-30. (Pubitemid 44829964)
11. Mao-Ying QL, Wang XW, Yang CJ, et al. Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats. Mol Brain 2012;5:16.
12. Feng QX, Wang W, Feng XY, et al. Astrocytic activation in thoracic spinal cord contributes to persistent pain in rat model of chronic pancreatitis. Neuroscience 2010;167:501-9.
13. Amin B, Hajhashemi V, Hosseinzadeh H, Abnous K. Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat. Neuroscience 2012;224:15-25.
14. Scholz J, Abele A, Marian C, et al. Low-dose methotrexate reduces peripheral nerve injury-evoked spinal microglial activation and neuropathic pain behavior in rats. Pain 2008;138:130-42.
15. Sweitzer S, De Leo J. Propentofylline: Glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol 2011;235-50.
16. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. P38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003;23:4017-22. (Pubitemid 36958419)
17. Zhuang ZY, Wen YR, Zhang DR, et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: Respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006;26:3551-60.
18. Sumracki NM, Hutchinson MR, Gentgall M, et al. The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica. PLoS One 2012;7:e38525.
19. Lu CH, Chao PC, Borel CO, et al. Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery. Anesth Analg 2004;99:1465-71. (Pubitemid 39407300)
20. Wordliczek J, Szczepanik AM, Banach M, et al. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci 2000;66:1155-64. (Pubitemid 30117782)
21. Anand P, Shenoy R, Palmer JE, et al. Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. Eur J Pain 2011;15:1040-8.
22. Ostenfeld T, Krishen A, Lai RY, et al. Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: A double-blind, placebo-controlled study. Eur J Pain 2012; epub ahead of print.